Allurion Technologies (ALURD) Net Equity Issued and Repurchased (2024 - 2025)
Allurion Technologies' (ALURD) quarterly Net Equity Issued and Repurchased came in at $14.5 million in Q1 2025, up 3735.71% YoY from $378000.0 in Q1 2024, and up 3735.71% on a QoQ basis from $378000.0 in Q1 2024.
Allurion Technologies (ALURD) Net Equity Issued and Repurchased (2024 - 2025) Analysis & Trends
Allurion Technologies (ALURD) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $14.5 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 14.50 Mn |
| Mar 31, 2025 | 14.50 Mn |
| Mar 31, 2024 | 378,000.00 |
| Mar 31, 2024 | 378,000.00 |